chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aspiration pleural cavity, Chest X-ray, Chest pain, Computerised tomogram, Cough
Clinical narrative: Back pain/ Back ache; Headaches; non-productive cough; This is a spontaneous report from a contactable consumer (patient's mother).  A 49-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Right on 27Mar2021 (Batch/Lot Number: ER8734) as DOSE 1, SINGLE for covid-19 immunization.  Medical history included breast cancer from Feb2020 to 25Sep2020 (left breast cancer, pertinent details: diagnosed via mammography, ultrasound and biopsy), mastectomy in Sep2020 (She had a mastectomy Sep2020 and all her margins were clear and she was cancer free), chemotherapy from May2020 to Jul2021.  Concomitant medication included One-A-Day Multivitamin since Oct2020. On 04Apr2021, the patient experienced back pain/ back, occasional headaches, and non-productive cough. The events were reported as serious - important medically event. The patient had lab tests and procedures on 16Oct2020 which included magnetic resonance imaging head: no abnormal findings to explain symptoms (No abnormal findings to explain symptoms. Specifically no metastatic disease in the brain).  Therapeutic measures were taken as a result of back pain/ back ache, occasional headaches, non-productive cough and included flexeril for pain. The clinical outcome of the events back pain/ back ache, headaches, non-productive cough was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Hypersensitivity, Lymphadenopathy, Malaise, Metastasis
Clinical narrative: Back pain/ Back ache; Headaches; non-productive cough; This is a spontaneous report from a contactable consumer (patient's mother).  A 49-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Right on 27Mar2021 (Batch/Lot Number: ER8734) as DOSE 1, SINGLE for covid-19 immunization.  Medical history included breast cancer from Feb2020 to 25Sep2020 (left breast cancer, pertinent details: diagnosed via mammography, ultrasound and biopsy), mastectomy in Sep2020 (She had a mastectomy Sep2020 and all her margins were clear and she was cancer free), chemotherapy from May2020 to Jul2021.  Concomitant medication included One-A-Day Multivitamin since Oct2020. On 04Apr2021, the patient experienced back pain/ back, occasional headaches, and non-productive cough. The events were reported as serious - important medically event. The patient had lab tests and procedures on 16Oct2020 which included magnetic resonance imaging head: no abnormal findings to explain symptoms (No abnormal findings to explain symptoms. Specifically no metastatic disease in the brain).  Therapeutic measures were taken as a result of back pain/ back ache, occasional headaches, non-productive cough and included flexeril for pain. The clinical outcome of the events back pain/ back ache, headaches, non-productive cough was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pulmonary mass
Clinical narrative: Back pain/ Back ache; Headaches; non-productive cough; This is a spontaneous report from a contactable consumer (patient's mother).  A 49-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Right on 27Mar2021 (Batch/Lot Number: ER8734) as DOSE 1, SINGLE for covid-19 immunization.  Medical history included breast cancer from Feb2020 to 25Sep2020 (left breast cancer, pertinent details: diagnosed via mammography, ultrasound and biopsy), mastectomy in Sep2020 (She had a mastectomy Sep2020 and all her margins were clear and she was cancer free), chemotherapy from May2020 to Jul2021.  Concomitant medication included One-A-Day Multivitamin since Oct2020. On 04Apr2021, the patient experienced back pain/ back, occasional headaches, and non-productive cough. The events were reported as serious - important medically event. The patient had lab tests and procedures on 16Oct2020 which included magnetic resonance imaging head: no abnormal findings to explain symptoms (No abnormal findings to explain symptoms. Specifically no metastatic disease in the brain).  Therapeutic measures were taken as a result of back pain/ back ache, occasional headaches, non-productive cough and included flexeril for pain. The clinical outcome of the events back pain/ back ache, headaches, non-productive cough was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acoustic stimulation tests abnormal, Deafness unilateral, Dizziness, Ear infection bacterial, Feeling abnormal
Clinical narrative: I woke up and could not hear; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received bnt162b2 (Pfizer BioNtech), second single dose via an unspecified route of administration, administered in arm left on 08Mar2021 at 10:00 (Batch/Lot Number: EN6204) for covid-19 immunisation at age of 68-year-old. The patient previously received first dose of bnt162b2 (Lot number: EN6200) on 15Feb2021 at 10:00 administered in arm left for covid-19 immunisation at age of 68-year-old. Medical history included allergies: seasonal allergies, and chocolate. There were no concomitant medications. No other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination. Two days after receiving the second vaccine on 11Mar2021, patient woke up and could not hear. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient had Covid test (Nasal swab) on 11Oct2021 was negative. The patient received antibiotic and dizzy pills as treatment. Outcome of the event was recovered with lasting effects (recovered with sequel) in 2021.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site pain
Clinical narrative: I woke up and could not hear; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received bnt162b2 (Pfizer BioNtech), second single dose via an unspecified route of administration, administered in arm left on 08Mar2021 at 10:00 (Batch/Lot Number: EN6204) for covid-19 immunisation at age of 68-year-old. The patient previously received first dose of bnt162b2 (Lot number: EN6200) on 15Feb2021 at 10:00 administered in arm left for covid-19 immunisation at age of 68-year-old. Medical history included allergies: seasonal allergies, and chocolate. There were no concomitant medications. No other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination. Two days after receiving the second vaccine on 11Mar2021, patient woke up and could not hear. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient had Covid test (Nasal swab) on 11Oct2021 was negative. The patient received antibiotic and dizzy pills as treatment. Outcome of the event was recovered with lasting effects (recovered with sequel) in 2021.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Deafness, SARS-CoV-2 test
Clinical narrative: I woke up and could not hear; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received bnt162b2 (Pfizer BioNtech), second single dose via an unspecified route of administration, administered in arm left on 08Mar2021 at 10:00 (Batch/Lot Number: EN6204) for covid-19 immunisation at age of 68-year-old. The patient previously received first dose of bnt162b2 (Lot number: EN6200) on 15Feb2021 at 10:00 administered in arm left for covid-19 immunisation at age of 68-year-old. Medical history included allergies: seasonal allergies, and chocolate. There were no concomitant medications. No other vaccine in four weeks and no other medications in two weeks. No COVID prior vaccination. Two days after receiving the second vaccine on 11Mar2021, patient woke up and could not hear. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient had Covid test (Nasal swab) on 11Oct2021 was negative. The patient received antibiotic and dizzy pills as treatment. Outcome of the event was recovered with lasting effects (recovered with sequel) in 2021.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blindness unilateral, Eye pain, Pain in extremity, Pyrexia, Thrombosis
Clinical narrative: Breakthrough Case
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dysarthria, Fine motor skill dysfunction, Guillain-Barre syndrome, Hypoaesthesia
Clinical narrative: Patient started with feeling fatigue and tingling in her hands. This progressed to worsening headaches and loss of ability to speak. She was rushed to hospital for stroke protocol. This has been a negative workup. She has since progressed to loss of ability to walk, loss of ability to feed herself, and is losing the ability to breathe. She has had numerous workups and several treatment attempts. It appears to be some sort of vaccine induced Amyotrophic Lateral Sclerosis. She is African American which is less common for ALS patients and she  has had autonomic instability which is unusual in ALS. She has been given ALS infusion which was unhelpful and she was given IgG infusions several months after her diagnosis which also was minimally helpful. Her prognosis is extremely poor.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paralysis
Clinical narrative: Patient started with feeling fatigue and tingling in her hands. This progressed to worsening headaches and loss of ability to speak. She was rushed to hospital for stroke protocol. This has been a negative workup. She has since progressed to loss of ability to walk, loss of ability to feed herself, and is losing the ability to breathe. She has had numerous workups and several treatment attempts. It appears to be some sort of vaccine induced Amyotrophic Lateral Sclerosis. She is African American which is less common for ALS patients and she  has had autonomic instability which is unusual in ALS. She has been given ALS infusion which was unhelpful and she was given IgG infusions several months after her diagnosis which also was minimally helpful. Her prognosis is extremely poor.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amyotrophic lateral sclerosis, Aphasia, Autonomic nervous system imbalance, Blood test, Dyspnoea
Clinical narrative: Patient started with feeling fatigue and tingling in her hands. This progressed to worsening headaches and loss of ability to speak. She was rushed to hospital for stroke protocol. This has been a negative workup. She has since progressed to loss of ability to walk, loss of ability to feed herself, and is losing the ability to breathe. She has had numerous workups and several treatment attempts. It appears to be some sort of vaccine induced Amyotrophic Lateral Sclerosis. She is African American which is less common for ALS patients and she  has had autonomic instability which is unusual in ALS. She has been given ALS infusion which was unhelpful and she was given IgG infusions several months after her diagnosis which also was minimally helpful. Her prognosis is extremely poor.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electromyogram, Fatigue, Feeding disorder, Gait inability, Headache
Clinical narrative: Patient started with feeling fatigue and tingling in her hands. This progressed to worsening headaches and loss of ability to speak. She was rushed to hospital for stroke protocol. This has been a negative workup. She has since progressed to loss of ability to walk, loss of ability to feed herself, and is losing the ability to breathe. She has had numerous workups and several treatment attempts. It appears to be some sort of vaccine induced Amyotrophic Lateral Sclerosis. She is African American which is less common for ALS patients and she  has had autonomic instability which is unusual in ALS. She has been given ALS infusion which was unhelpful and she was given IgG infusions several months after her diagnosis which also was minimally helpful. Her prognosis is extremely poor.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immunoglobulin therapy, Infusion, Magnetic resonance imaging, Nerve conduction studies, Paraesthesia
Clinical narrative: Patient started with feeling fatigue and tingling in her hands. This progressed to worsening headaches and loss of ability to speak. She was rushed to hospital for stroke protocol. This has been a negative workup. She has since progressed to loss of ability to walk, loss of ability to feed herself, and is losing the ability to breathe. She has had numerous workups and several treatment attempts. It appears to be some sort of vaccine induced Amyotrophic Lateral Sclerosis. She is African American which is less common for ALS patients and she  has had autonomic instability which is unusual in ALS. She has been given ALS infusion which was unhelpful and she was given IgG infusions several months after her diagnosis which also was minimally helpful. Her prognosis is extremely poor.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Erythema, Oropharyngeal discomfort, Paraesthesia oral
Clinical narrative: New symptoms are that my heart rate racing when exercising or walking recently. Recently numbing on back of my head and my face also. Headaches, right eye flickering affecting vision periodically. Inside Left leg shooting pain in foot while driving.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blepharospasm, Blood test normal, Electromyogram normal, Headache, Hypoaesthesia
Clinical narrative: New symptoms are that my heart rate racing when exercising or walking recently. Recently numbing on back of my head and my face also. Headaches, right eye flickering affecting vision periodically. Inside Left leg shooting pain in foot while driving.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging normal, Pain, Pain in extremity, Palpitations, Visual impairment
Clinical narrative: New symptoms are that my heart rate racing when exercising or walking recently. Recently numbing on back of my head and my face also. Headaches, right eye flickering affecting vision periodically. Inside Left leg shooting pain in foot while driving.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: pt admitted to hospital with SOB, hypoxia, dx with COVID pneumonia; placed on remdesivir, decadron and O2; HX of ESRD, DM, CAD, HTN; while in hospital, pt suffered cardiac arrest and required intubation with mechanical ventilation;; pt's condition worsened, hypotension and poor O2 sats in spite of ventilation; family made pt a DNR; condition deteriorated and pt died in the hospital
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Cardiac arrest, Death, Dyspnoea, Endotracheal intubation
Clinical narrative: pt admitted to hospital with SOB, hypoxia, dx with COVID pneumonia; placed on remdesivir, decadron and O2; HX of ESRD, DM, CAD, HTN; while in hospital, pt suffered cardiac arrest and required intubation with mechanical ventilation;; pt's condition worsened, hypotension and poor O2 sats in spite of ventilation; family made pt a DNR; condition deteriorated and pt died in the hospital
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: General physical health deterioration, Hypotension, Hypoxia, Mechanical ventilation, Oxygen saturation decreased
Clinical narrative: pt admitted to hospital with SOB, hypoxia, dx with COVID pneumonia; placed on remdesivir, decadron and O2; HX of ESRD, DM, CAD, HTN; while in hospital, pt suffered cardiac arrest and required intubation with mechanical ventilation;; pt's condition worsened, hypotension and poor O2 sats in spite of ventilation; family made pt a DNR; condition deteriorated and pt died in the hospital
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Patient reports a sudden onset of paresthesia's in his hands and feet, that is progressively been worsening.  Loss of sensation is been to such a degree that he has had one traumatic fall on outstretched hands, and 1 incidence of burning of his left wrist.  He reports that symptoms began suddenly after 40 days of receiving the Johnson & Johnson: Vaccine.  He denies any other symptoms of note.  I do believe this could be a episode of acute inflammatory demyelinating polyneuropathy.  Given the mild severity (diminished reflexes and paresthesia's only) and lack of other neurologic signs, I do not believe that hospitalization or immuno modulating therapy is necessary at this time.  No evidence of facial paralysis or vision complaints..
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood thyroid stimulating hormone, Fall, Glycosylated haemoglobin, Lipids, Metabolic function test
Clinical narrative: Patient reports a sudden onset of paresthesia's in his hands and feet, that is progressively been worsening.  Loss of sensation is been to such a degree that he has had one traumatic fall on outstretched hands, and 1 incidence of burning of his left wrist.  He reports that symptoms began suddenly after 40 days of receiving the Johnson & Johnson: Vaccine.  He denies any other symptoms of note.  I do believe this could be a episode of acute inflammatory demyelinating polyneuropathy.  Given the mild severity (diminished reflexes and paresthesia's only) and lack of other neurologic signs, I do not believe that hospitalization or immuno modulating therapy is necessary at this time.  No evidence of facial paralysis or vision complaints..
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Sensory loss, Subacute inflammatory demyelinating polyneuropathy, Thermal burn
Clinical narrative: Patient reports a sudden onset of paresthesia's in his hands and feet, that is progressively been worsening.  Loss of sensation is been to such a degree that he has had one traumatic fall on outstretched hands, and 1 incidence of burning of his left wrist.  He reports that symptoms began suddenly after 40 days of receiving the Johnson & Johnson: Vaccine.  He denies any other symptoms of note.  I do believe this could be a episode of acute inflammatory demyelinating polyneuropathy.  Given the mild severity (diminished reflexes and paresthesia's only) and lack of other neurologic signs, I do not believe that hospitalization or immuno modulating therapy is necessary at this time.  No evidence of facial paralysis or vision complaints..
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: pt brought to ED via EMS after going into cardiac arrest @ home; CPR done @ home and en route to hospital; pt intubated; recently recovering from COVID that did require a hospitalization; family made pt a DNR; pt extubated and passed away in the hospital
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cardiac arrest, Death, Endotracheal intubation, Resuscitation
Clinical narrative: pt brought to ED via EMS after going into cardiac arrest @ home; CPR done @ home and en route to hospital; pt intubated; recently recovering from COVID that did require a hospitalization; family made pt a DNR; pt extubated and passed away in the hospital
Age: 53.0
Sex: F
Vaccine: COVID19, UNK, COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Rheumatoid arthritis
Clinical narrative: decreased kidney function; increased pain; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received second dose of BNT162B2 in Oct2021 (at age of 53 years old) at single dose for COVID-19 immunization. Medica history and concomitant medications were not reported. Historical vaccine included first dose of COVID-19 Vaccine (unknown manufacturer) on unspecified date for COVID-19 immunization. Patient experienced increased pain (patient states pain is at a 7-8 now and her baseline is 2-3) on 15Oct2021 and decreased kidney function on 29Oct2021. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19, UNK, COVID19
Symptoms: Pain, Renal impairment
Clinical narrative: decreased kidney function; increased pain; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received second dose of BNT162B2 in Oct2021 (at age of 53 years old) at single dose for COVID-19 immunization. Medica history and concomitant medications were not reported. Historical vaccine included first dose of COVID-19 Vaccine (unknown manufacturer) on unspecified date for COVID-19 immunization. Patient experienced increased pain (patient states pain is at a 7-8 now and her baseline is 2-3) on 15Oct2021 and decreased kidney function on 29Oct2021. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chills, Electrocardiogram, Fatigue, Headache
Clinical narrative: felt horrible; slept most of the day; Everything hurts, legs, arms, head, feet; extremely fatigued; chills; continue to get a runny nose on and off; unable to concentrate or focus on any task for very long; The effects from the vaccine have severely disrupted my life; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: ER8729 and Expiration Date was not reported), via an unspecified route of administration, administered in left arm on 20Apr2021 at 13:00 hours (at the age of 58-year-old) as dose 1, single for COVID-19 immunisation. Patient had no medical history/underlying conditions and before taking the vaccine her health was fine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior to vaccination. Patient had no known allergies. The patient concomitant medications were not reported. On 21Apr2021 (Wednesday), patient felt horrible, slept most of the day, felt horrible ever since (10 days total), everything hurts, legs, arms, head, feet, extremely fatigued, had chills for a few days, continue to get a runny nose on and off, unable to concentrate or focus on any task for very long. The effects from the vaccine have severely disrupted her life. Patient stated it was all she can do to move around and take care of herself and was struggling to function. Patient had been tested for COVID-19 on 27Apr2021 via nasal swab test, result was negative. Patient had emergency room/department or urgent care visit for the events. Patient received no treatment for the events. The outcome of all the events was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: felt horrible; slept most of the day; Everything hurts, legs, arms, head, feet; extremely fatigued; chills; continue to get a runny nose on and off; unable to concentrate or focus on any task for very long; The effects from the vaccine have severely disrupted my life; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: ER8729 and Expiration Date was not reported), via an unspecified route of administration, administered in left arm on 20Apr2021 at 13:00 hours (at the age of 58-year-old) as dose 1, single for COVID-19 immunisation. Patient had no medical history/underlying conditions and before taking the vaccine her health was fine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior to vaccination. Patient had no known allergies. The patient concomitant medications were not reported. On 21Apr2021 (Wednesday), patient felt horrible, slept most of the day, felt horrible ever since (10 days total), everything hurts, legs, arms, head, feet, extremely fatigued, had chills for a few days, continue to get a runny nose on and off, unable to concentrate or focus on any task for very long. The effects from the vaccine have severely disrupted her life. Patient stated it was all she can do to move around and take care of herself and was struggling to function. Patient had been tested for COVID-19 on 27Apr2021 via nasal swab test, result was negative. Patient had emergency room/department or urgent care visit for the events. Patient received no treatment for the events. The outcome of all the events was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Disturbance in attention, Fatigue, Hypersomnia, Loss of personal independence in daily activities
Clinical narrative: felt horrible; slept most of the day; Everything hurts, legs, arms, head, feet; extremely fatigued; chills; continue to get a runny nose on and off; unable to concentrate or focus on any task for very long; The effects from the vaccine have severely disrupted my life; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: ER8729 and Expiration Date was not reported), via an unspecified route of administration, administered in left arm on 20Apr2021 at 13:00 hours (at the age of 58-year-old) as dose 1, single for COVID-19 immunisation. Patient had no medical history/underlying conditions and before taking the vaccine her health was fine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior to vaccination. Patient had no known allergies. The patient concomitant medications were not reported. On 21Apr2021 (Wednesday), patient felt horrible, slept most of the day, felt horrible ever since (10 days total), everything hurts, legs, arms, head, feet, extremely fatigued, had chills for a few days, continue to get a runny nose on and off, unable to concentrate or focus on any task for very long. The effects from the vaccine have severely disrupted her life. Patient stated it was all she can do to move around and take care of herself and was struggling to function. Patient had been tested for COVID-19 on 27Apr2021 via nasal swab test, result was negative. Patient had emergency room/department or urgent care visit for the events. Patient received no treatment for the events. The outcome of all the events was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Pain, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: felt horrible; slept most of the day; Everything hurts, legs, arms, head, feet; extremely fatigued; chills; continue to get a runny nose on and off; unable to concentrate or focus on any task for very long; The effects from the vaccine have severely disrupted my life; This is a spontaneous report from a contactable consumer (patient). A 58-year-old non-pregnant female patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: ER8729 and Expiration Date was not reported), via an unspecified route of administration, administered in left arm on 20Apr2021 at 13:00 hours (at the age of 58-year-old) as dose 1, single for COVID-19 immunisation. Patient had no medical history/underlying conditions and before taking the vaccine her health was fine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior to vaccination. Patient had no known allergies. The patient concomitant medications were not reported. On 21Apr2021 (Wednesday), patient felt horrible, slept most of the day, felt horrible ever since (10 days total), everything hurts, legs, arms, head, feet, extremely fatigued, had chills for a few days, continue to get a runny nose on and off, unable to concentrate or focus on any task for very long. The effects from the vaccine have severely disrupted her life. Patient stated it was all she can do to move around and take care of herself and was struggling to function. Patient had been tested for COVID-19 on 27Apr2021 via nasal swab test, result was negative. Patient had emergency room/department or urgent care visit for the events. Patient received no treatment for the events. The outcome of all the events was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 58.0
Sex: F
Vaccine: COVID19, UNK, UNK
Symptoms: Cerebrovascular accident, Fall, Head injury, Loss of consciousness, Magnetic resonance imaging
Clinical narrative: stroke Oct 4th,  Patient denies any new symptoms of headache, loss of vision but does report vision has changed with some blurred vision and dizziness at times when she's doing aggressive exercise where her head is down and then comes up quickly. Symptoms of no libido, vaginal dryness, hot flashes at night, blurred vision and some new dizziness since stroke.
Age: 58.0
Sex: F
Vaccine: COVID19, UNK, UNK
Symptoms: Cerebrovascular accident, Dizziness, Hot flush, Loss of libido, Magnetic resonance imaging head
Clinical narrative: stroke Oct 4th,  Patient denies any new symptoms of headache, loss of vision but does report vision has changed with some blurred vision and dizziness at times when she's doing aggressive exercise where her head is down and then comes up quickly. Symptoms of no libido, vaginal dryness, hot flashes at night, blurred vision and some new dizziness since stroke.
Age: 58.0
Sex: F
Vaccine: COVID19, UNK, UNK
Symptoms: Vision blurred, Vulvovaginal dryness
Clinical narrative: stroke Oct 4th,  Patient denies any new symptoms of headache, loss of vision but does report vision has changed with some blurred vision and dizziness at times when she's doing aggressive exercise where her head is down and then comes up quickly. Symptoms of no libido, vaginal dryness, hot flashes at night, blurred vision and some new dizziness since stroke.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Chills, Dizziness, Eye pain
Clinical narrative: increasing intracranial pressure; blurred vision; brain fog; dizziness; partial numbness; ringing in the ears; Growing thyroid nodules; spinal tap; pain in her neck, and in between her shoulders, and headache; right arm numbness; right thoracic outlet syndrome; This is an initial spontaneous report from a contactable Consumer (Patient). A 51-Year-old female consumer received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot number: not provided; Expiration date: not provided) via an unspecified route of administration on 03Apr2021 (age at vaccination 51-year-old) as dose 2, single for Covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown; Expiration date: unknown) via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. On an unspecified date caller was continuing to experience blurred vision, brain fog, dizziness, partial numbness, ringing in the ears. Growing thyroid nodules were also discovered on one of the tests she had. Caller also reported having had a spinal tap since the vaccine, for concerns about increasing intracranial pressure, that helped to relieve pain in her neck, and in between her shoulders, and headache although she reports these symptoms are building back up. Caller also has had right arm numbness. The patient underwent lab tests and procedures which included Lumbar puncture with an unknown result on an unspecified date. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Hypoaesthesia oral, Idiopathic intracranial hypertension, Lumbar puncture
Clinical narrative: increasing intracranial pressure; blurred vision; brain fog; dizziness; partial numbness; ringing in the ears; Growing thyroid nodules; spinal tap; pain in her neck, and in between her shoulders, and headache; right arm numbness; right thoracic outlet syndrome; This is an initial spontaneous report from a contactable Consumer (Patient). A 51-Year-old female consumer received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot number: not provided; Expiration date: not provided) via an unspecified route of administration on 03Apr2021 (age at vaccination 51-year-old) as dose 2, single for Covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown; Expiration date: unknown) via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. On an unspecified date caller was continuing to experience blurred vision, brain fog, dizziness, partial numbness, ringing in the ears. Growing thyroid nodules were also discovered on one of the tests she had. Caller also reported having had a spinal tap since the vaccine, for concerns about increasing intracranial pressure, that helped to relieve pain in her neck, and in between her shoulders, and headache although she reports these symptoms are building back up. Caller also has had right arm numbness. The patient underwent lab tests and procedures which included Lumbar puncture with an unknown result on an unspecified date. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Muscular weakness, Myalgia, Nausea, Neck pain
Clinical narrative: increasing intracranial pressure; blurred vision; brain fog; dizziness; partial numbness; ringing in the ears; Growing thyroid nodules; spinal tap; pain in her neck, and in between her shoulders, and headache; right arm numbness; right thoracic outlet syndrome; This is an initial spontaneous report from a contactable Consumer (Patient). A 51-Year-old female consumer received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot number: not provided; Expiration date: not provided) via an unspecified route of administration on 03Apr2021 (age at vaccination 51-year-old) as dose 2, single for Covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown; Expiration date: unknown) via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. On an unspecified date caller was continuing to experience blurred vision, brain fog, dizziness, partial numbness, ringing in the ears. Growing thyroid nodules were also discovered on one of the tests she had. Caller also reported having had a spinal tap since the vaccine, for concerns about increasing intracranial pressure, that helped to relieve pain in her neck, and in between her shoulders, and headache although she reports these symptoms are building back up. Caller also has had right arm numbness. The patient underwent lab tests and procedures which included Lumbar puncture with an unknown result on an unspecified date. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia, Sleep disorder, Thoracic outlet syndrome, Thyroid mass
Clinical narrative: increasing intracranial pressure; blurred vision; brain fog; dizziness; partial numbness; ringing in the ears; Growing thyroid nodules; spinal tap; pain in her neck, and in between her shoulders, and headache; right arm numbness; right thoracic outlet syndrome; This is an initial spontaneous report from a contactable Consumer (Patient). A 51-Year-old female consumer received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot number: not provided; Expiration date: not provided) via an unspecified route of administration on 03Apr2021 (age at vaccination 51-year-old) as dose 2, single for Covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown; Expiration date: unknown) via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. On an unspecified date caller was continuing to experience blurred vision, brain fog, dizziness, partial numbness, ringing in the ears. Growing thyroid nodules were also discovered on one of the tests she had. Caller also reported having had a spinal tap since the vaccine, for concerns about increasing intracranial pressure, that helped to relieve pain in her neck, and in between her shoulders, and headache although she reports these symptoms are building back up. Caller also has had right arm numbness. The patient underwent lab tests and procedures which included Lumbar puncture with an unknown result on an unspecified date. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus, Vision blurred
Clinical narrative: increasing intracranial pressure; blurred vision; brain fog; dizziness; partial numbness; ringing in the ears; Growing thyroid nodules; spinal tap; pain in her neck, and in between her shoulders, and headache; right arm numbness; right thoracic outlet syndrome; This is an initial spontaneous report from a contactable Consumer (Patient). A 51-Year-old female consumer received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot number: not provided; Expiration date: not provided) via an unspecified route of administration on 03Apr2021 (age at vaccination 51-year-old) as dose 2, single for Covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown; Expiration date: unknown) via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. On an unspecified date caller was continuing to experience blurred vision, brain fog, dizziness, partial numbness, ringing in the ears. Growing thyroid nodules were also discovered on one of the tests she had. Caller also reported having had a spinal tap since the vaccine, for concerns about increasing intracranial pressure, that helped to relieve pain in her neck, and in between her shoulders, and headache although she reports these symptoms are building back up. Caller also has had right arm numbness. The patient underwent lab tests and procedures which included Lumbar puncture with an unknown result on an unspecified date. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling abnormal, Hypoaesthesia, Intracranial pressure increased, Lumbar puncture
Clinical narrative: increasing intracranial pressure; blurred vision; brain fog; dizziness; partial numbness; ringing in the ears; Growing thyroid nodules; spinal tap; pain in her neck, and in between her shoulders, and headache; right arm numbness; right thoracic outlet syndrome; This is an initial spontaneous report from a contactable Consumer (Patient). A 51-Year-old female consumer received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot number: not provided; Expiration date: not provided) via an unspecified route of administration on 03Apr2021 (age at vaccination 51-year-old) as dose 2, single for Covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown; Expiration date: unknown) via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. On an unspecified date caller was continuing to experience blurred vision, brain fog, dizziness, partial numbness, ringing in the ears. Growing thyroid nodules were also discovered on one of the tests she had. Caller also reported having had a spinal tap since the vaccine, for concerns about increasing intracranial pressure, that helped to relieve pain in her neck, and in between her shoulders, and headache although she reports these symptoms are building back up. Caller also has had right arm numbness. The patient underwent lab tests and procedures which included Lumbar puncture with an unknown result on an unspecified date. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Thoracic outlet syndrome, Thyroid mass, Tinnitus, Vision blurred
Clinical narrative: increasing intracranial pressure; blurred vision; brain fog; dizziness; partial numbness; ringing in the ears; Growing thyroid nodules; spinal tap; pain in her neck, and in between her shoulders, and headache; right arm numbness; right thoracic outlet syndrome; This is an initial spontaneous report from a contactable Consumer (Patient). A 51-Year-old female consumer received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot number: not provided; Expiration date: not provided) via an unspecified route of administration on 03Apr2021 (age at vaccination 51-year-old) as dose 2, single for Covid-19 immunization. The patients medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown; Expiration date: unknown) via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. On an unspecified date caller was continuing to experience blurred vision, brain fog, dizziness, partial numbness, ringing in the ears. Growing thyroid nodules were also discovered on one of the tests she had. Caller also reported having had a spinal tap since the vaccine, for concerns about increasing intracranial pressure, that helped to relieve pain in her neck, and in between her shoulders, and headache although she reports these symptoms are building back up. Caller also has had right arm numbness. The patient underwent lab tests and procedures which included Lumbar puncture with an unknown result on an unspecified date. The outcome of the events was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Chest discomfort, Chest pain, Dizziness, Dyspnoea
Clinical narrative: Syncope (roughly 1 minute) , given epi pen and taken to ER by ambulance. Nausea , rapid heart rate, burning sensation in stomach and up throat (ongoing - 3 weeks) , muscle weakness/fatigue (ongoing-3 weeks), Insomnia (started approximately one week after vaccine)
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Flushing, Hyperhidrosis, Hypoaesthesia, Tremor
Clinical narrative: Syncope (roughly 1 minute) , given epi pen and taken to ER by ambulance. Nausea , rapid heart rate, burning sensation in stomach and up throat (ongoing - 3 weeks) , muscle weakness/fatigue (ongoing-3 weeks), Insomnia (started approximately one week after vaccine)
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspepsia, Echocardiogram normal, Electrocardiogram normal, Heart rate increased, Insomnia
Clinical narrative: Syncope (roughly 1 minute) , given epi pen and taken to ER by ambulance. Nausea , rapid heart rate, burning sensation in stomach and up throat (ongoing - 3 weeks) , muscle weakness/fatigue (ongoing-3 weeks), Insomnia (started approximately one week after vaccine)
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test normal, Muscle fatigue, Muscular weakness, Nausea, Syncope
Clinical narrative: Syncope (roughly 1 minute) , given epi pen and taken to ER by ambulance. Nausea , rapid heart rate, burning sensation in stomach and up throat (ongoing - 3 weeks) , muscle weakness/fatigue (ongoing-3 weeks), Insomnia (started approximately one week after vaccine)
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: Syncope (roughly 1 minute) , given epi pen and taken to ER by ambulance. Nausea , rapid heart rate, burning sensation in stomach and up throat (ongoing - 3 weeks) , muscle weakness/fatigue (ongoing-3 weeks), Insomnia (started approximately one week after vaccine)
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Depression, Dysmenorrhoea, Heavy menstrual bleeding, Mood altered
Clinical narrative: Severe menstrual bleeding and cramps; Severe menstrual bleeding and cramps; Very significant change in mood; Depression; This is a spontaneous report from a contactable consumer reporting same events under the same suspect product for 4 patients. This is 1 of 4 reports.  A 39-year-old non-pregnant female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (COMIRNATY; solution for injection, Lot Number: Ep7534, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 17Mar2021 at 08:30 (39-year-old at the time of vaccination) as dose 1, single for COVID-19 immunization. Medical history included milk allergy from (known allergies: Dairy) and covid-19. There were no concomitant medications. The patient did not have covid post vaccination. Patient did not take any medication in two weeks. Since the vaccination, the patient has not been tested for COVID-19. On 18Mar2021 at 13:00, the patient experienced severe menstrual bleeding, cramps, very significant change in mood and depression. It was reported that severe menstrual bleeding and cramps. Very significant change in mood. Depression symptoms when patient have never had an issue before. She did not seek medical attention because she felt embarrassed and do not feel confident in her doctor or insurance. She heard many women including 4 she closes with have similar issue, so she wanted to report it finally. The patient received second dose of BNT162B2 (COMIRNATY; solution for injection, Lot Number: Ew0162, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 14Apr2021 (39-year-old at the time of vaccination) as dose 2, single for COVID-19 immunization. No therapeutic measure has been taken for the events. The clinical outcome of the events was recovering at the time of this report.  Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101418500 same reporter/drug, different patients.